Clinical Study
Prediction of Early Response to Chemotherapy in Lung Cancer by Using Diffusion-Weighted MR Imaging
Table 1
Patient and tumor characteristics between the PR and SD groups.
| Characteristics | PR () | SD () | |
| Age (years) | 66 (56–69) | 59 (56–66) | 0.587 | Female/male | 1/7 | 7/10 | 0.205 | Smoker | 4 | 9 | 0.891 | Lesion location | | | 0.389 | Right lobe | 3 | 11 | | Left lobe | 5 | 6 | | Histological subtype | | | 0.089 | Squamous cell carcinomas | 7 | 7 | | Adenocarcinomas | 1 | 8 | | Adenosquamous carcinomas | 0 | 2 | | Stage | | | 0.456 | III A | 3 | 8 | | III B | 5 | 7 | | IV | 0 | 2 | | ADC at baseline (10−3 mm2/s) | | | 0.517 | Change of longest diameter (cm) | | | 0.007 | Change of shortest diameter (cm) | | | 0.045 | Change of ADC value (10−3 mm2/s) | | | 0.004 |
|
|
ADC: apparent diffusion coefficient; PR: partial response; SD: stable disease.
|